SUNFLOWER MEDICAL LIMITEDActive

Company number 04514281Private limited companyIncorporated 2002
⚠ Accounts overdue. The next accounts were due on 30 Sep 2026 and had not been filed when the register was last updated.

Key figures

£2,001,028+2.6%
Net assets 2022
+2.6%
Average annual growth 2021–2022
01 m2 m3 m20212022

Like most small UK companies, SUNFLOWER MEDICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2022
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m20212022

Dividends

from the accounts
2021

Dividends paid in the financial year: £800,000 (225% of the profit for the year).

Filed accounts2021–2022
20212022
Profit for the year355,170—
Cash at bank and in hand13,5724,260
Total assets2,684,7703,158,926
Total liabilities669,7451,094,007
Net assets / total equity1,951,1342,001,028
Average number of employees5350
Dividends paid800,000—

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SUNFLOWER MEDICAL LIMITED

Company

SUNFLOWER MEDICAL LIMITED is a private limited company registered with Companies House under company number 04514281. It was incorporated on 19 Aug 2002. Its status is active. The registered office is in Bradford (BD4). Its nature of business (SIC 2007) is manufacture of other furniture (31090).

Accounts

The latest accounts in the database are for 2022 (period ending 31 Dec 2022); the company files small company accounts. Net assets were £2,001,028, up 2.6% on the previous year. Cash at bank and in hand was £4,260. Total assets were £3,158,926 and total liabilities £1,094,007. The company had an average of 50 employees. Figures are available for 2 financial years (2021–2022).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 8 Sep 2027.